Biography:
Jeremy Everett is the Professor of Pharmaceutical Technologies at the University of Greenwich UK and Visiting Professor in the Faculty of Medicine at Imperial College. He studies genotype to metabotype correlations in obesity and ageing and is co-inventor on a recent patent on an anti-obesogenic agent. He is a co-discoverer of pharmacometabonomics.
Jeremy received his BSc and PhD in chemistry from Nottingham University, UK. He postdoc’d at McMaster and McGill Universities. Jeremy is a Fellow of the Royal Society of Chemistry and a Chartered Chemist, with over 100 publications and patents, over 5,500 citations and an h-index of 32.
